Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
McKesson
Mallinckrodt
Moodys
Fish and Richardson
Express Scripts
Cipla
Boehringer Ingelheim

Generated: August 17, 2018

DrugPatentWatch Database Preview

R-pharm Us Llc Company Profile

« Back to Dashboard

Summary for R-pharm Us Llc
International Patents:208
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for R-pharm Us Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-002 Oct 16, 2007 RX Yes Yes 7,125,899*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-001 Oct 16, 2007 RX Yes Yes RE41911*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-001 Oct 16, 2007 RX Yes Yes 6,670,384*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-001 Oct 16, 2007 RX Yes Yes 7,125,899*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-001 Oct 16, 2007 RX Yes Yes 7,312,237*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-002 Oct 16, 2007 RX Yes Yes 7,312,237*PED ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for R-pharm Us Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-001 Oct 16, 2007 6,605,599 ➤ Try a Free Trial
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;IV (INFUSION) 022065-002 Oct 16, 2007 6,605,599 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for R-PHARM US LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 15 mg/vial and 45 mg/vial, single-use vials ➤ Subscribe 2012-04-16

Non-Orange Book US Patents for R-pharm Us Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,598,215 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases ➤ Try a Free Trial
6,576,651 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones ➤ Try a Free Trial
8,569,347 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases ➤ Try a Free Trial
6,605,599 Epothilone derivatives ➤ Try a Free Trial
RE41893 Epothilone derivatives ➤ Try a Free Trial
RE40387 Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for R-pharm Us Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1019389/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: IXABEPILONE; REGISTRATION NUMBER/DATE: SWISSMEDIC 58880 27.02.2009
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Teva
Dow
McKinsey
Chinese Patent Office
Medtronic
QuintilesIMS
UBS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.